MedPageToday
MedPage Today) — CHICAGO — The WARRIOR trial was not able to prove that intensive medical therapy reduced major adverse cardiovascular events (MACE) in women with ischemia but no obstructive disease.
For symptomatic patients with suspected…
Read More
Benefit for Women’s INOCA Eludes Familar Cardiovascular Meds in WARRIOR
Stephania Catt
09:19
MedPage Today) — CHICAGO — The WARRIOR trial was not able to prove that intensive medical therapy reduced major adverse cardiovascular events (MACE) in women with ischemia but no obstructive disease. For symptomatic patients with suspected…
